Your browser doesn't support javascript.
loading
Enhanced Donor Antigen Presentation by B Cells Predicts Acute Cellular Rejection and Late Outcomes After Transplantation.
Ashokkumar, Chethan; Ningappa, Mylarappa; Raghu, Vikram; Mazariegos, George; Higgs, Brandon W; Morgan, Paul; Remaley, Lisa; Fazzolare Martin, Tamara; Holzer, Pamela; Trostle, Kevin; Xu, Qingyong; Zeevi, Adriana; Squires, James; Soltys, Kyle; Horslen, Simon; Khanna, Ajai; Ganoza, Armando; Sindhi, Rakesh.
Afiliación
  • Ashokkumar C; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Ningappa M; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Raghu V; Division of Pediatric Gastroenterology, Hepatology, and Nutrition, UPMC Children's Hospital Pittsburgh, PA.
  • Mazariegos G; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Higgs BW; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Morgan P; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Remaley L; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Fazzolare Martin T; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Holzer P; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Trostle K; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Xu Q; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Zeevi A; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Squires J; Division of Pediatric Gastroenterology, Hepatology, and Nutrition, UPMC Children's Hospital Pittsburgh, PA.
  • Soltys K; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Horslen S; Division of Pediatric Gastroenterology, Hepatology, and Nutrition, UPMC Children's Hospital Pittsburgh, PA.
  • Khanna A; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Ganoza A; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
  • Sindhi R; Department of Surgery, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh, PA.
Transplant Direct ; 10(3): e1589, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38414976
ABSTRACT

Background:

Enhanced B-cell presentation of donor alloantigen relative to presentation of HLA-mismatched reference alloantigen is associated with acute cellular rejection (ACR), when expressed as a ratio called the antigen presenting index (API) in an exploratory cohort of liver and intestine transplant (LT and IT) recipients.

Methods:

To test clinical performance, we measured the API using the previously described 6-h assay in 84 LT and 54 IT recipients with median age 3.3 y (0.05-23.96). Recipients experiencing ACR within 60 d after testing were termed rejectors.

Results:

We first confirmed that B-cell uptake and presentation of alloantigen induced and thus reflected the alloresponse of T-helper cells, which were incubated without and with cytochalasin and primaquine to inhibit antigen uptake and presentation, respectively. Transplant recipients included 76 males and 62 females. Rejectors were tested at median 3.6 d before diagnosis. The API was higher among rejectors compared with nonrejectors (2.2 ±â€…0.2 versus 0.6 ±â€…0.04, P value = 1.7E-09). In logistic regression and receiver-operating-characteristic analysis, API ≥1.1 achieved sensitivity, specificity, and positive and negative predictive values for predicting ACR in 99 training set samples. Corresponding metrics ranged from 80% to 88% in 32 independent posttransplant samples, and 73% to 100% in 20 independent pretransplant samples. In time-to-event analysis, API ≥1.1 predicted higher incidence of late donor-specific anti-HLA antibodies after API measurements in LT recipients (P = 0.011) and graft loss in IT recipients (P = 0.008), compared with recipients with API <1.1, respectively.

Conclusions:

Enhanced donor antigen presentation by circulating B cells predicts rejection after liver or intestine transplantation as well as higher incidence of DSA and graft loss late after transplantation.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transplant Direct Año: 2024 Tipo del documento: Article País de afiliación: Panamá Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transplant Direct Año: 2024 Tipo del documento: Article País de afiliación: Panamá Pais de publicación: Estados Unidos